Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2003
02/20/2003WO2002096927A3 Ribozyme based treatment of female reproductive diseases
02/20/2003WO2002096422A3 Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
02/20/2003WO2002094200A3 Pulmonary administration of chemically modified insulin
02/20/2003WO2002089815A3 Disinfecting and solubilizing steroid compositions
02/20/2003WO2002085789A3 Magnesium di-pot assium edta complex and method of administration
02/20/2003WO2002080668A3 Antimicrobial formulations
02/20/2003WO2002078602A3 Transdermal delivery of pergolide
02/20/2003WO2002076398A3 Improved forms of pharmaceutically active agents and method for manufacture thereof
02/20/2003WO2002069936A3 Pharmaceutical composition of ibuprofen
02/20/2003WO2002067852A3 A controlled release pharmaceutical composition
02/20/2003WO2002064109A3 Mucoadhesive pharmaceutical formulations
02/20/2003WO2002064026A3 Treating pulmonary disorders with gaseous agent causing repletion of gsno
02/20/2003WO2002060406A3 Veterinary dermatologic composition
02/20/2003WO2002051427A8 Improved and stable extract from hypericum perforatum l., method for the production thereof and its use as a topical medicament
02/20/2003WO2002043705A3 Aerodynamically light vaccine for active pulmonary immunization
02/20/2003WO2002028420A9 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
02/20/2003WO2002028180B1 Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof
02/20/2003WO2002024623A3 Novel alkanoic acid derivatives
02/20/2003WO2002024164A3 Method for granulation of active substances by low pressure extrusion to obtain directly compressible granules
02/20/2003WO2002024158A8 Pulmonary delivery in treating disorders of the central nervous system
02/20/2003WO2002022156A8 Topical formulations for delivery of interleukin-11
02/20/2003WO2002019842A2 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
02/20/2003WO2002015940A3 Solution of an oxazolidinone antibiotic drug
02/20/2003WO2001093850B1 Methods and compositions using sulodexide for the treatment of diabetic nephropathy
02/20/2003WO2001056547B1 Preparation of aqueous clear solution dosage forms with bile acids
02/20/2003US20030036746 Devices for intrabody delivery of molecules and systems and methods utilizing same
02/20/2003US20030036697 Hollow microspheres with controlled fragility for medical use
02/20/2003US20030036568 Permeation enhancers
02/20/2003US20030036563 Carboxyvinylpolymer neutralized as a gel-forming agent or a polyacrylamide-isoparaffin and ethanol, isopropanol or diethylene glycol monoethyl ether as a solvent
02/20/2003US20030036542 Derivatives of pyrimido[6.1-a]isoquinolin-4-one
02/20/2003US20030036535 Physiological method of improving vision
02/20/2003US20030036527 Promoting mucociliary or cough clearance of retained mucus secretions from the lungs, sinuses, upper airways, ears, eyes, genitourinary tract, spermatozoa, ovaries, fallopian tubes, neutrophils, and macrophages
02/20/2003US20030036525 Hyaluronic acid and/or a salt thereof associated with/bound with an effective amount of anti-sense to the gene implicated in the disease or condition
02/20/2003US20030036520 Contacting the gastrointestinal site of delivery with an agent that causes a temporary disruption of the mucosal lining; and concurrently or subsequently contacting with a nucleic acid or a cell comprising a nucleic acid
02/20/2003US20030036518 Artificial polymeric membrane structure, method for preparing same, method for preparing this polymer, particle and film containing this structure
02/20/2003US20030035850 Hemorrhoidal compositions and method of use
02/20/2003US20030035845 Composition for sustained release of non-aggregated erythropoietin
02/20/2003US20030035842 Lipobeads and their production
02/20/2003US20030035841 Edible film formulations containing maltodextrin
02/20/2003US20030035840 Bupropion hydrochloride; antidepressants, psychological disorders
02/20/2003US20030035839 Multilayer tablets; side effect reduction
02/20/2003US20030035838 Drug delivery system exhibiting permeability control
02/20/2003US20030035837 Mixture of drug with retarder; sustained release
02/20/2003US20030035836 Oral controlled release pharmaceutical composition for once-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
02/20/2003US20030035835 Protective overcoatings
02/20/2003US20030035834 Sustained release verapamil pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
02/20/2003US20030035833 Solid drug in aqueous solutions; efferverscence
02/20/2003US20030035832 Compression of drug and adjuvant
02/20/2003US20030035831 Pharmaceutical compositions for buccal delivery of pain relief medications
02/20/2003US20030035830 Method of administering liposomal encapsulated taxane
02/20/2003US20030035829 Liposomal compositions for the delivery of nucleic acid catalysts
02/20/2003US20030035828 Antiallergens; sustained release; transdermal administering
02/20/2003US20030035826 Water soluble active material and polymer mixture
02/20/2003US20030035825 Therapeutic pad and a method for treatment of common illnesses
02/20/2003US20030035823 Feed adjuvant; atomizing nozzle, drying, precipitation
02/20/2003US20030035820 Crosslinked keratin; thin film; wound healing agents, tissues, diffusion membranes
02/20/2003US20030035819 Skin care composition that mediates cell to cell communication
02/20/2003US20030035812 Administering vaccine
02/20/2003US20030035787 Polyanhydrides with biologically active degradation products
02/20/2003US20030035785 Skin protection composition
02/20/2003US20030035778 Methods and compositions for the dry powder formulation of interferon
02/20/2003US20030035776 Drug particle in aerosol
02/20/2003US20030035775 Inhalation administering; mixture of drug and solvent
02/20/2003US20030035774 Salt/ion pair medicinal aerosol formulation
02/20/2003DE29624397U1 Product for retarding and gentle release of substances into the body - consists of compressed carrier material which is insoluble in water and gastrointestinal fluids, an active agent and an optional shell which is soluble
02/20/2003CA2701551A1 Polysaccharide-containing compositions and use thereof
02/20/2003CA2457385A1 Improved enteric formulation of fluoxetin
02/20/2003CA2457314A1 Percutaneous absorption preparations
02/20/2003CA2456833A1 Polysaccharide-containing compositions and use thereof
02/20/2003CA2456808A1 Pharmaceutical composition comprising a water/oil/water double microemulsion incorporated in a solid support
02/20/2003CA2456713A1 Improved pharmaceutical composition containing a ppar alpha agent and a process for preparing it
02/20/2003CA2456706A1 Drug release system for controlled therapy
02/20/2003CA2456328A1 Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof
02/20/2003CA2456322A1 Compositions and methods to prevent abuse of opioids
02/20/2003CA2456144A1 A group of novel anti-cancer compounds with specific structure
02/20/2003CA2456052A1 Surfactant compounds and uses thereof
02/20/2003CA2456034A1 Sustained-release medicines
02/20/2003CA2455420A1 Compositions and methods to prevent abuse of opioids
02/20/2003CA2455391A1 Nutritional supplements and methods of using same
02/20/2003CA2455336A1 Peptides that bind to atherosclerotic lesions
02/20/2003CA2454684A1 Eukaryotic cells and method for preserving cells
02/20/2003CA2454173A1 Stabilized oral suspension formulation
02/20/2003CA2453884A1 Micronutrient phosphates as dietary and health supplements
02/20/2003CA2419389A1 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
02/19/2003EP1284151A1 Topical treatment of pain and to promote healing including capsaicin as an analgesic
02/19/2003EP1284146A1 Liposomes containing hydrophobic iodo compound
02/19/2003EP1284145A1 2-(3,4-Dihydroxyphenyl)ethyl substituted carbonic acid derivatives and their use
02/19/2003EP1284143A1 A process for the preparation of pharmaceutical formulations containing lactoferrin description
02/19/2003EP1284138A1 Plaster
02/19/2003EP1284137A1 Nonoral preparation having three-layer structure
02/19/2003EP1283828A1 Novel polymorph v of torasemide
02/19/2003EP1283725A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
02/19/2003EP1283724A1 Systems and methods for topical treatment with nitric oxide
02/19/2003EP1283720A1 Recombinant or purified polyclonal antibodies for treating allergy
02/19/2003EP1283710A1 Use of a celecoxib composition for fast pain relief
02/19/2003EP1283708A2 Use of biguanide derivatives for making a medicine having a wound healing effect
02/19/2003EP1283706A1 Dosage of transdermal delivery systems
02/19/2003EP1283705A1 Transdermal therapeutical system with a reduced tendency of the active substance to crystallize
02/19/2003EP1283704A2 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents
02/19/2003EP1283703A1 Rapidly disintegrating tablet and process for the manufacture thereof
1 ... 2176 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 ... 2991